Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Pool Corporation Announces Upcoming Investor Conference Participation
-
SPAR Group, Inc. Announces Timing of Fiscal 2026 Second Quarter Results Conference Call
-
Viasat Releases First Quarter Fiscal Year 2027 Financial Results
-
Streamex Corp. to Report Second Quarter 2026 Results and Host Business & Corporate Update Call
-
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
-
Postal Realty Trust, Inc. Reports Second Quarter 2026 Results
-
Lime Announces Second Quarter 2026 Financial Results
-
Interparfums, Inc. Reports 2026 Second Quarter And Half Year Results And Reaffirms Full Year Sales And Earnings Guidance
-
Q2 2026 Open House: Everything is Up. More Contracts. More Revenue. More Margin. Except Costs. Those are Down.
-
Ionic Digital to Participate in Canaccord Genuity’s 46th Annual Growth Conference
-
Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
-
Suja Life Reports Second Quarter 2026 Financial Results
-
Sonoco Aligns Global Consumer Businesses Under Single Leadership Structure
-
OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance
-
Amwell® Announces Results for the Second Quarter 2026
-
Astera Labs Reports Second Quarter 2026 Financial Results
-
Latham Group, Inc. Reports Second Quarter 2026 Financial Results
-
GigaCloud Technology Inc to Participate in Oppenheimer 29th Annual Technology, Internet & Communications Conference
-
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
-
Tocvan to Present at the OTCQB Virtual Investor Conference on August 5
-
Workhorse Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
-
BlackLine Announces Second Quarter Financial Results
-
Chaince Securities, LLC to Serve as Exclusive Sales Agent for ZJK Industrial Co., Ltd.’s (NASDAQ: ZJK) US$9.8 Million At-the-Market Offering Program
-
T3 Defense Subsidiary Tiltan Receives Purchase Order from Leading Israeli Defense Contractor for Next-Generation Infrared Electro-Optical Simulation Program
-
Globus Maritime Announces Annual Meeting of Shareholders
-
Cricut, Inc. Reports Second Quarter 2026 Financial Results
-
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
-
Paylocity Announces Fourth Quarter and Fiscal 2026 Financial Results
-
Crane NXT to Participate in the Oppenheimer 29th Annual Technology, Internet & Communications Conference
-
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
-
Crane NXT to Participate in the Oppenheimer 29th Annual Technology, Internet & Communications Conference
-
Streamex Corp. to Report Second Quarter 2026 Results and Host Business & Corporate Update Call
-
Vroom Announces Second Quarter 2026 Results
-
Credit Acceptance Announces Second Quarter 2026 Results
-
Green Thumb Industries Reports Second Quarter 2026 Results
-
Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Flywire Reports Second Quarter 2026 Financial Results
-
The Chefs' Warehouse, Inc. Commences Refinancing Process
-
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Security National Financial Corporation Announces 2026 Q2 Earnings Call
-
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
-
SLR Investment Corp. Announces Quarter Ended June 30, 2026 Financial Results
-
Flywire Reports Second Quarter 2026 Financial Results
-
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Pacira BioSciences Reports Second Quarter 2026 Financial Results
-
Capital Southwest Urges Shareholders to Support Authorized Shares Proposal
-
Skyward Group Reports Second Quarter 2026 Results
-
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026

